Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: FROVA

Summary for Tradename: FROVA

Suppliers: see list3
patent expirations by year for

Clinical Trials for: FROVA

Frovatriptan and Menstrual Migraine
Status: Terminated Condition: Frovatriptan; Menstrual Migraine

Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine
Status: Completed Condition: Migraine

Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals
Status: Completed Condition: Migraines; Bleeding; Spotting

Frovatriptan as a Transitional Therapy in Medication Overuse Headache
Status: Recruiting Condition: Medication Overuse Headache; Analgesic Overuse Headache

A Research Study To Evaluate If Frovatriptan Is Safe And Effective In Preventing Migraine Headache After Fasting
Status: Completed Condition: Migraine

Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
Status: Completed Condition: Menstrual Migraine (MM) Headaches

A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine
Status: Completed Condition: Migraine

Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches
Status: Completed Condition: Migraine

A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine
Status: Completed Condition: Migraine

Renal Denervation by Allegro System in Patients With Resistant Hypertension
Status: Recruiting Condition: Renal Denervation; Resistant Hypertension; Standard Medication

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms
frovatriptan succinate
TABLET;ORAL021006Nov 8, 2001RXYes5,464,864<disabled><disabled>
Endo Pharms
frovatriptan succinate
TABLET;ORAL021006Nov 8, 2001RXYes5,616,603<disabled><disabled>
Endo Pharms
frovatriptan succinate
TABLET;ORAL021006Nov 8, 2001RXYes5,637,611<disabled><disabled>
Endo Pharms
frovatriptan succinate
TABLET;ORAL021006Nov 8, 2001RXYes5,827,871<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: FROVA

Drugname Dosage Strength RLD Submissiondate
frovatriptan succinateTablets2.5 mgFrova3/9/2011

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology